Quantcast
Last updated on April 23, 2014 at 17:08 EDT

Latest Myostatin Stories

2011-07-02 00:00:32

Atlas Therapeutics Corporation (OTCBB: ATTH), the manufacturer of the revolutionary myostatin inhibitor, MYO-T12®, has announced that hockey legend Wayne Gretzky is joining its primary national promotion and marketing team. Marina Del Rey, CA (PRWEB) July 01, 2011 Atlas Therapeutics Corporation (OTCBB: ATTH), the manufacturer of the revolutionary myostatin inhibitor, MYO-T12®, has announced that hockey legend Wayne Gretzky is joining its primary national promotion and marketing...

2011-05-13 00:00:29

InHealth Media is pleased to announce that it has been named the media agency of record for the marketing of MYO-T12®, a revolutionary myostatin modulating supplement distributed by The Muscle Company. Delray Beach FL (PRWEB) May 12, 2011 InHealth Media is pleased to announce that it has been named the media agency of record for the marketing of MYO-T12®, a revolutionary myostatin modulating supplement distributed by The Muscle Company. MYO-T12® is the world's first clinically...

2011-03-22 21:32:17

Inhibiting a growth factor called myostatin in mice with chronic kidney disease halted the muscle wasting common in the disorder and even reduced inflammation, indicating a new strategy for treating muscle wasting, said researchers from Baylor College of Medicine in a report in The FASEB Journal. "Preventing muscle wasting would be helpful because studies show that people who have lost muscle mass are more likely to suffer disability and death," said Dr. William Mitch, professor of medicine...

2011-02-04 13:35:00

CALVERTON, Md., Feb. 4, 2011 /PRNewswire/ -- MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company. The Company will be accepting bids for any or all of its assets until 4:00 p.m., March 3, 2011....

6f4a1beecb32e8cbf78f490a02a664061
2010-12-09 10:14:37

Researchers at the University of Hawai'i at Mānoa have developed innovative techniques that could have profound effects on congenital cervical vertebrae malformation research. In the cover-featured research article of the November issue of Molecular Reproduction and Development, researchers looked into congenital cervical vertebrae malformation in humans that can cause neural problems and increase susceptibility to stillbirth in women. Research advancement on...

2010-09-09 05:59:00

CAMBRIDGE, Massachusetts, September 9, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB (ActRIIB) class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts. The collaboration will...

2010-03-10 12:30:39

Inhibition of myostatin results in fish with 'six-pack abs' A 10-year effort by a University of Rhode Island scientist to develop transgenic rainbow trout with enhanced muscle growth has yielded fish with what have been described as six-pack abs and muscular shoulders that could provide a boost to the commercial aquaculture industry. Terry Bradley, a URI professor of fisheries and aquaculture, said his research into the inhibition of myostatin, a protein that slows muscle growth, has obtained...

2009-11-11 18:16:43

A study appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with certain degenerative muscle disorders. Severe weakness of the quadriceps is a defining feature of several neuromuscular disorders. Researchers at Nationwide Children's Hospital have shown that a gene delivery strategy that produces follistatin "“ a naturally occurring protein that inhibits myostatin,...

2009-06-11 11:03:24

Knockout of myostatin, a growth factor that limits muscle growth, can decrease body fat and promote resistance against developing atherosclerosis, or "hardening" of the arteries, according to a new study conducted in mice. The results will be presented Thursday at The Endocrine Society's 91st Annual Meeting in Washington, D.C."Obesity increases the risk of atherosclerosis, which accounts for 75% of all cardiovascular events, such as heart attacks and strokes," said study co-author Shalender...

2009-02-27 08:10:07

Newly-published research from the University of Calgary suggests that muscle in obese people and Type 2 diabetes may be conspiring against them Research by kinesiology investigator Dustin Hittel, PhD, has proven that muscle in extremely obese individuals produces large amounts of a protein called myostatin, which normally inhibits muscle growth"”suggesting that for Type 2 diabetics, and the very obese, the task of getting healthy may be more difficult than initially thought. It has been...